
Related
Related Companies
NSE
BSE
New Delhi: Drug firm Sanofi India on Tuesday reported a net profit of Rs 132.9 crore for the quarter ended September 30, 2020. The company had posted a net profit of Rs 126.6 crore in the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
Consolidated revenue from operations stood at Rs 686.6 crore for the quarter under consideration. It was Rs 779.1 crore for the same period a year ago, it added.
"The financial results for the quarter ended September 30, 2020 are not comparable with that of corresponding quarter in 2019 and previous quarters of 2020 due to completion of slump sale transaction on May 29, 2020, which resulted in transfer of Ankleshwar manufacturing facility and few products to Zentiva Pvt Ltd," the company said.
Shares of Sanofi India closed at Rs 8,394.65 per scrip on BSE, up 0.95 per cent from its previous close.
Consolidated revenue from operations stood at Rs 686.6 crore for the quarter under consideration. It was Rs 779.1 crore for the same period a year ago, it added.
"The financial results for the quarter ended September 30, 2020 are not comparable with that of corresponding quarter in 2019 and previous quarters of 2020 due to completion of slump sale transaction on May 29, 2020, which resulted in transfer of Ankleshwar manufacturing facility and few products to Zentiva Pvt Ltd," the company said.
Shares of Sanofi India closed at Rs 8,394.65 per scrip on BSE, up 0.95 per cent from its previous close.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.